Conformal Medical, Inc. announced today, the next-generation CLAAS® AcuFORM™ Left Atrial Appendage Occlusion (LAAO) System will be highlighted during the 2024 Transcatheter Cardiovascular Therapeutics ...

Chukwudi Obiagwu and Cardiac Electrophysiologist Dr. Darpan Kumar, the Left Atrial Appendage Occlusion, or LAAO, procedure reduces the risk of stroke without the need for costly blood thinners.

AuriGen Medical, a medical device company specializing in left atrial appendage occlusion (LAAO) technology, today announced ...

The atrial appendage occluder market is on a remarkable growth trajectory, with a projected market size of USD 983.5 million in 2023, expected to surge to USD 8,193.0 million by 2033. This growth is ...

A medical milestone has been achieved in Deep East Texas as the first Left Atrial Appendage Occlusion (LAAO) procedure utilizing the Boston Scientific Watchman FLX Pro device was successfully ...

Study will assess the Company's Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures. NASHUA, N.H., Oct. 1, 2024 ...

Study will assess the Company's Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures. "I am excited about the new CLAAS ...

Welcome to Abbott's third quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...